Clinical Trials

Showing trials with last updates posted in 2025.

NCT07188194 | NOT_YET_RECRUITING
32 participants

ADAM'S Prognostic Markers

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-23
Start Date:
2025-09-30
Completion:
2026-09-30
Conditions
  • Acute Disseminated Encephalomyelitis
No Results Yet
NCT07187908 | RECRUITING | PHASE2
1076 participants

Efbemalenograstim Alfa for Primary/Secondary Prevention in Patients With Solid Tumors at High Risk for Febrile Neutropenia (FN) or Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in FN

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2025-01-01
Completion:
2026-10-31
Conditions
  • Primary/Secondary Prevention
  • High Risk for Febrile Neutropenia of Chemotherapy Regimens
  • Intermediate Risk of Chemotherapy Regimens Associated With Other Risk Factors in Febrile Neutropenia
Interventions
  • DRUG
No Results Yet
NCT07187791 | NOT_YET_RECRUITING
200 participants

CT KUB in Renal Cysts

Study Type:
OBSERVATIONAL
Last Updated:
2025-09-23
Start Date:
2025-10-01
Completion:
2027-03-31
Conditions
  • CT KUB
  • Renal Cyst
Interventions
  • DEVICE
No Results Yet
NCT07187713 | RECRUITING | PHASE4
300 participants

ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2025-09-20
Completion:
2026-08-31
Conditions
  • Hypertensive Nephropathy
  • Auto Immune Disorders
  • Chronic Kidney Disease
  • Chronc Kidney Disease Stage 5
  • Chronic Kidney Disease (Stage 3-4)
  • Chronic Kidney Disease (Stages 4 and 5)
  • Microalbuminuria
  • Diabetic Nephropathies
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page